BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11013015)

  • 1. An economic assessment of Apligraf (Graftskin) for the treatment of hard-to-heal venous leg ulcers.
    Schonfeld WH; Villa KF; Fastenau JM; Mazonson PD; Falanga V
    Wound Repair Regen; 2000; 8(4):251-7. PubMed ID: 11013015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of graftskin (Apligraf) in difficult-to-heal venous leg ulcers.
    Bello YM; Falabella AF
    J Wound Care; 2002 May; 11(5):182-3. PubMed ID: 12055943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective, randomized trial of Unna's boot versus Duoderm CGF hydroactive dressing plus compression in the management of venous leg ulcers.
    Cordts PR; Hanrahan LM; Rodriguez AA; Woodson J; LaMorte WW; Menzoian JO
    J Vasc Surg; 1992 Mar; 15(3):480-6. PubMed ID: 1538504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of compression therapy using Unna's boot on the self-esteem of patients with venous leg ulcers.
    Salome GM; de Brito MJ; Ferreira LM
    J Wound Care; 2014 Sep; 23(9):442-4, 446. PubMed ID: 25284296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.
    Falanga V; Sabolinski M
    Wound Repair Regen; 1999; 7(4):201-7. PubMed ID: 10781211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic outcomes with graftskin for hard-to-heal venous leg ulcers: a single-center experience.
    Kirsner RS; Fastenau J; Falabella A; Valencia I; Long R; Eaglstein WH
    Dermatol Surg; 2002 Jan; 28(1):81-2. PubMed ID: 11991277
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of three adjunct cellular/tissue-derived products used in the management of chronic venous leg ulcers.
    Carter MJ; Waycaster C; Schaum K; Gilligan AM
    Value Health; 2014 Dec; 17(8):801-13. PubMed ID: 25498775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of compression therapy with Unna's boot on the functional status of VLU patients.
    L de Lima E; Salomé GM; de Brito Rocha MJ; Ferreira LM
    J Wound Care; 2013 Oct; 22(10):558-61. PubMed ID: 24142078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and economic impact of Apligraf for the treatment of nonhealing venous leg ulcers.
    Fivenson D; Scherschun L
    Int J Dermatol; 2003 Dec; 42(12):960-5. PubMed ID: 14636194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using bioelectrical impedance analysis to compare the treatment of edema with the Unna's boot and noncompression in individuals with venous ulcers.
    Cardoso LV; de Fátima Guerreiro Godoy M; Czorny RCN; Pereira de Godoy JM
    J Vasc Nurs; 2019 Mar; 37(1):58-63. PubMed ID: 30954200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomised controlled study of four-layer compression versus Unna's Boot for venous ulcers.
    Polignano R; Bonadeo P; Gasbarro S; Allegra C
    J Wound Care; 2004 Jan; 13(1):21-4. PubMed ID: 14969023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the cost-effectiveness of electric stimulation therapy in non-healing venous leg ulcers.
    Taylor RR; Sladkevicius E; Guest JF
    J Wound Care; 2011 Oct; 20(10):464, 466, 468-72. PubMed ID: 22067884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cost effectiveness of Apligraf treatment of diabetic foot ulcers.
    Redekop WK; McDonnell J; Verboom P; Lovas K; Kalo Z
    Pharmacoeconomics; 2003; 21(16):1171-83. PubMed ID: 14594438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue engineering in wound repair.
    Falanga VJ
    Adv Skin Wound Care; 2000; 13(2 Suppl):15-9. PubMed ID: 11074998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcomes and cost-effectiveness of an externally applied electroceutical device in managing venous leg ulcers in clinical practice in the UK.
    Guest JF; Ayoub N; Greaves T
    J Wound Care; 2015 Dec; 24(12):572, 574-80. PubMed ID: 26654737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Unna's boot as a treatment for venous ulcers.
    Barr DM
    Nurse Pract; 1996 Jul; 21(7):55-6, 61-4, 71-2 passim; quiz 76-7. PubMed ID: 8823788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compression for venous leg ulcers.
    O'Meara S; Cullum NA; Nelson EA
    Cochrane Database Syst Rev; 2009 Jan; (1):CD000265. PubMed ID: 19160178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of weekly LED therapy at 625 nm on the treatment of chronic lower ulcers.
    Siqueira CP; de Paula Ramos S; Gobbi CA; Shigaki L; Kashimoto RK; Venâncio EJ; de Oliveira Toginho Filho D; Castaldin AG; Felinto AS; Silva FP; Silva RB; Dias IF
    Lasers Med Sci; 2015 Jan; 30(1):367-73. PubMed ID: 25315022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost effectiveness of using carboxymethylcellulose dressing compared with gauze in the management of exuding venous leg ulcers in Germany and the USA.
    Guest JF; Ruiz FJ; Mihai A; Lehman A
    Curr Med Res Opin; 2005 Jan; 21(1):81-92. PubMed ID: 15881478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.